QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Inergetics, Inc. (NRTI) Continues Distribution Build For Martha Stewart Essentials 4 comments
    Oct 31, 2013 10:53 AM | about stocks: NRTI

    Leading developer of nutritional supplements, Inergetics announced that both Cardinal Health and Hy-Vee have agreed to add the new Martha Stewart Essentials line of supplements to their respective nutritional portfolios this fall.

    "Cardinal Health, distributor to thousands of retail doors, is on board with this new venture," commented CEO, Michael James. "Cardinal Health is a premier organization and we're proud to partner with them as we move forward in building Martha Stewart Essentials distribution."

    Hy-Vee is the first food chain to bring in the line and in addition it will also mark the first time the Martha Stewart brand will adorn the shelves of food stores. Hy-Vee is set to feature the Martha Stewart Essentials displays in their nutritional section to solidify active brand visibility.

    "Martha Stewart Essentials is generating real excitement in this burgeoning category and we're proud of the fact that we have this American icon as part of our portfolio," stated Marshall Post, EVP.

    "Martha Stewart, author of her latest national best-selling book, Living the Good Long Life, understands healthy living. She lives and breathes it and knows today's consumers have been waiting for her to enter this market for some time," commented CMO, Jim Kras.

    Martha Stewart Essentials is a line of supplements developed specifically to address women concerned with supporting their overall health, as well as support active lifestyles long into old age while keeping health care costs down. The line features six condition-specific, whole-food-based formulas, which include: Multivitamin, Hair, Skin & Nails, Graceful Aging, Digestive Health, Bone Support, and Menopause Support.

    Inergetics plans to promptly support the line with National FSIs (free-standing insert), print and digital interactive efforts designed to accelerate consumer trial.

    To learn more about Inergetics, visit inergetics.com

    QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.qualitystocks.net

    Stocks: NRTI
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (4)
Track new comments
  • Brooks Was Here
    , contributor
    Comments (35) | Send Message
    Great new additions to their distribution pipeline. The stock seems pretty stuck around $0.14, even with recent positive news. 3Q earnings are coming out within the next few weeks, any insight on where things could go?
    2 Nov 2013, 05:48 PM Reply Like
  • Jasper85
    , contributor
    Comments (436) | Send Message
    Now = Ground floor cause not many people seem to know what's happening with this stock.
    Revenue was in thousands $ last year, this year with the complete new turnaround management.....millions already!


    Proof? :


    Not priced in this stock yet, keep accumulating before the market finds out.
    9 Nov 2013, 08:32 AM Reply Like
  • Brooks Was Here
    , contributor
    Comments (35) | Send Message
    Thanks Jasper, I have seen that PR (several times actually) but it really didn't move the stock price. I think many people watching this stock are waiting to see if the sales equate to profit in the 3Q. Also, MSO has posted another quarterly loss which may be steering investors away.


    I am also curious to see if they can increase revenue enough to cover the future royalty payments as noted in the 10-Q:


    The Company entered into a license agreement with minimum royalty payments totaling $1,800,000, $2,100,000, $2,700,000, $3,200,000 and $3,800,000 for each of the years ended 2014, 2015, 2016, 2017 and 2018, respectively. $450,000 was paid as of June 30, 2013.


    I see the long-term potential here and am anxious to see the 3Q results. Hopefully management didn't eat up all of the revenue with expenses.
    9 Nov 2013, 03:00 PM Reply Like
  • Jasper85
    , contributor
    Comments (436) | Send Message
    Obviously I hear what you're saying Brooks :)
    Recent Q3 (EPS 0,06) from MSO was decent if you compare it to 3Q12(EPS 0,76) + the CEO switch, hence the stock breakout these days.


    As to your comment on the royalties payments, I reckon they will cover those royalties in less then 1 quarter.
    The amount of shipped product in this quarter will be the forward guidance, I'm sure Mr. James the CEO will point it out in the 10Q soon.
    New nationwide distribution contracts were recently signed with Hy-Vee and Cardinal Health, who knows if CVS will be on soon as well??


    Let's not forget that they will receive around $3 million due to tax regularities in moving the company to New Jersey.
    The only expenses I foresee are the expenses that come with ramping up production at DaVita and promotional activities (for the products as well as the investors promo for the company :)


    If the markets gets aware of this OTC stock with the bright future, who knows where this will be in year.
    The new record revenue has yet to be included in the stockprice.


    (BTW, royalties for 2013 were around $ 450k)
    10 Nov 2013, 12:38 PM Reply Like
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.